Covered recipient · General Payments record
DARREN BALLARD
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,105.32
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.59 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.15 | 4 |
| Gilead Sciences, Inc. | $80.12 | 4 |
| Janssen Biotech, Inc. | $64.95 | 3 |
| GENZYME CORPORATION | $30.93 | 1 |
| Ardelyx, Inc. | $30.03 | 1 |
| QOL Medical, LLC | $25.51 | 1 |
| Lilly USA, LLC | $22.53 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.58 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103272221 | CMS |
| ABBVIE INC. | $23.56 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103272223 | CMS |
| ABBVIE INC. | $24.50 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103272225 | CMS |
| ABBVIE INC. | $19.51 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103272227 | CMS |
| Ardelyx, Inc. | $30.03 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146670311 | CMS |
| GENZYME CORPORATION | $30.93 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139679421 | CMS |
| Gilead Sciences, Inc. | $18.78 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783787 | CMS |
| Gilead Sciences, Inc. | $18.16 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783789 | CMS |
| Gilead Sciences, Inc. | $18.56 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783791 | CMS |
| Gilead Sciences, Inc. | $24.62 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783793 | CMS |
| Janssen Biotech, Inc. | $24.23 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078591673 | CMS |
| Janssen Biotech, Inc. | $19.35 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078591767 | CMS |
| Janssen Biotech, Inc. | $21.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078591695 | CMS |
| Lilly USA, LLC | $22.53 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136117441 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.37 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151038018 | CMS |
| QOL Medical, LLC | $25.51 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147719309 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.